{"id":"W2028690273","doi":"10.1002/cncr.25931","title":"A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sorafenib; Everolimus; Renal cell carcinoma; Common Terminology Criteria for Adverse Events; Sunitinib; Adverse effect; Rash; Internal medicine; Response Evaluation Criteria in Solid Tumors; Toxicity; Urology; Pharmacology; Oncology; Gastroenterology; Phases of clinical research; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000965072,0.0001665199,0.0003843867,0.00008314941,0.00003819989,0.000004350246,0.00005887162,0.00003193031,0.0002011866],"category_scores_gemma":[0.000007652446,0.0001305,0.00008091865,0.00008890233,0.0000507706,0.0000411525,0.00002869424,0.00007502553,0.000005483102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007749617,"about_ca_system_score_gemma":0.0001080842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000499351,"about_ca_topic_score_gemma":0.00004042793,"domain_scores_codex":[0.9990304,0.00003569643,0.0002588778,0.0002893097,0.0001680797,0.0002177022],"domain_scores_gemma":[0.9992822,0.00004150123,0.0001253303,0.0002830129,0.0001111583,0.0001568453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.05423244,0.06493623,0.1895404,0.007261539,0.001987266,0.002030443,0.1033021,0.00003535489,0.5209569,0.00008224366,0.01142107,0.04421393],"study_design_scores_gemma":[0.08080219,0.04469795,0.06750078,0.00008313161,0.003963582,0.0000411217,0.005179111,0.0004186947,0.7953221,0.0001010024,0.001464979,0.0004254071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943079,0.002474716,0.00004934969,0.00001848969,0.00007374994,0.001409723,0.00004006281,0.0000143997,0.001611657],"genre_scores_gemma":[0.9974968,0.00003280585,0.001060305,0.00006576053,0.00005419398,0.0002531321,0.000006739163,0.00003381991,0.0009964126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2743651,"threshold_uncertainty_score":0.5321636,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08551078911157818,"score_gpt":0.3209049142133281,"score_spread":0.2353941251017499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}